ROIV Roivant Sciences
- 11.030
- +0.150+1.38%
- 11.030
- 0.0000.00%
Roivant Sciences News
4: Statement of changes in beneficial ownership of securities-Director Fitzgerald Meghan
4: Statement of changes in beneficial ownership of securities-Director MOMTAZEE JAMES C
4: Statement of changes in beneficial ownership of securities-Director Oren Ilan
4: Statement of changes in beneficial ownership of securities-Director Epperly Melissa B,
4: Statement of changes in beneficial ownership of securities-Officer Kumar Rakhi
4: Statement of changes in beneficial ownership of securities-Officer Pulik Richard
4: Statement of changes in beneficial ownership of securities-Officer Gline Matthew
4: Statement of changes in beneficial ownership of securities-Officer Pulik Richard
4: Statement of changes in beneficial ownership of securities-Officer Kumar Rakhi
4: Statement of changes in beneficial ownership of securities-Officer Venker Eric
Roivant Sciences | 3: Initial statement of beneficial ownership of securities-10% Owner Ramaswamy Vivek
Roivant Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Pulik Richard
Roivant Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Sukhatme Mayukh
Roivant Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Gline Matthew
Roivant Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sumitomo Chemical Co., Ltd.(0.00%),Sumitomo Pharma Co., Ltd.(0.00%)
Roivant Sciences | 8-K: Current report
Roivant Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Venker Eric
Roivant Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Kumar Rakhi
Roivant Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Gline Matthew
Roivant Sciences | 4: Statement of changes in beneficial ownership of securities-Director MANCHESTER KEITH S
Analysis
Price Target
No Data
